News and Opinions  –  2024

ReAct's Impact Report 2023!

Share the article

2024-05-29

In 2023, ReAct made significant strides in advancing the fight against antibiotic resistance. We are proud to share ReAct annual impact report for work carried out in 2023. ReAct has grown into a dynamic network, intensifying our efforts to combat antibiotic resistance on global, regional, and national scales.

 

Click image to download report (PDF).

The four ReAct nodes have collaborated effectively, influencing change from community initiatives to the highest levels of global political discourse.To highlight our wide-ranging activities and engagements, ReAct’s Impact Report showcases key achievements during 2023.

“ReAct has persistently advocated for increased action, putting health equity and public health needs at the centre of policy and financing discussions, we are proud that our efforts have contributed to striking a better balance between global health threats and the response needed.”

says Anna Sjöblom, Director ReAct Europe.

ReAct drives global momentum to address antibiotic resistance

10 focus areas of ReAct’s work in 2023

1. ReAct continued to prepare and mobilize for the UN General Assembly High-Level Meeting (HLM) on Antimicrobial Resistance (AMR) in 2024, including engaging with stakeholders, advocating for inclusive governance, and ensuring LMIC perspectives are represented. This included organizing stakeholder meetings, such as the ReAct Africa Annual Conference and Uppsala Dialogue Meeting, to generate concrete suggestions for the UN HLM on AMR and ensure fair representation of civil society, academia, and communities.

2. ReAct supports the implementation of National Action Plans (NAPs) on AMR in several low- and middle-income countries (LMICs), including Zambia and Kenya, with a focus on facilitating multi-sectoral collaboration and community engagement.

3. We continued taking forward the “Empowered Communities” series of meetings, organized jointly by ReAct Latin America, PAHO and South Centre, to tackle AMR in Latin America and the Caribbean. The series involves indigenous community representatives, academics and artists, human, animal and environmental health workers to work on the multiple dimensions of AMR.

4. We also expanded the Antibiotic Smart Communities (ASC) initiative to more countries, providing a blueprint for community-driven approaches to address antibiotic resistance. For example, the ASC framework was piloted in Indonesia, and the model has gained significant attention from stakeholders.

5. ReAct advocated for reforms to the global market-driven research and development (R&D) system for new antibiotics, pushing for an approach that prioritizes public health needs and ensures equitable access in LMICs. ReAct’s work contributed to the inclusion of access requirements in the European Parliament’s report on the revised EU pharmaceutical legislation, as well as the introduction of more appropriate incentive models by the newly established European Health Emergency and Response Authority.

6. ReAct engaged with the newly established Multi-Stakeholder Partnership Platform on AMR, contributing to the shaping of priorities and positions of the civil society group.

7. We continued promoting youth engagement and education initiatives to raise awareness and inspire future champions to address antibiotic resistance.

8. ReAct expanded the use of participatory learning tools, such as the Alforja Educativa, in Latin American countries to promote awareness and behavioural change among children and communities.

9. We strengthened the role of the faith sector and women’s groups in AMR awareness and community mobilization efforts in the African context.

10. ReAct its ongoing publication and dissemination of research, case studies, and advocacy materials to influence policy and practice on AMR at the global, regional, and national levels.

Looking ahead: ReAct’s commitment to tackling antibiotic resistance

As we move forward, ReAct remains dedicated to accelerating progress in the fight against antibiotic resistance. Our focus for the coming years will be on further strengthening collaborations with diverse stakeholders, advocating for increased political will and financial investments, and supporting the implementation of effective interventions at the community level.

We will continue to champion health equity and ensure that the voices of those most affected by AMR are heard in global policy discussions. ReAct is also committed to exploring innovative approaches and seeking new sources of funding to sustain our work and expand our impact.